Skip to main content
    V

    VistaGen Therapeutics Inc (VTGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.19
    +0.00 (+2.01%)

    Market Cap: $8.01M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    VistaGen Therapeutics Inc (VTGN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    VistaGen Therapeutics (VTGN) has a latest price of $0.19 on Nov 17, 2026, 96.3% below its 52-week high of $5.14. Its price fell 95.1% over the past 12 months. The month-end price fell 99.9% over the 10 years through Oct 2026, a compound annual decline of 48.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $118.62 in Oct 2016 and its lowest $0.17 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VTGN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VTGN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 23.0%, and over 6 months it fell 70.2%. The month-end price fell 94.7% over the 3 years through Oct 2026, a compound annual decline of 62.5%.

    PeriodChange
    1 month-7.4%
    3 months-23.0%
    6 months-70.2%
    12 months-95.1%
    12 months, with dividends-95.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-94.7%-62.5%
    5 years-99.8%-70.0%
    10 years-99.9%-48.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 181.2%, and its weakest was 2022, when it fell 94.7%.

    YearCloseChange
    2026 through Oct 2026$0.17-74.6%
    2025$0.66-77.6%
    2024$2.95-42.6%
    2023$5.14+66.2%
    2022$3.09-94.7%
    2021$58.56+0.5%
    2020$58.26+181.2%
    2019$20.72-54.0%
    2018$45.05+35.1%
    2017$33.33-70.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 14.9% below its 50-day average of $0.22 and 55.1% below its 200-day average of $0.42.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.19
    52-week high$5.14-96.3%
    52-week low$0.16+17.5%
    50-day average$0.22-14.9%
    200-day average$0.42-55.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.2%.

    MeasureValue
    1-year beta1.88
    Largest fall, 1 year-96.7%
    Largest fall, 3 years-97.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VTGN

    What is VTGN's 1-year price change?

    VistaGen Therapeutics's price fell 95.1% over the past 12 months. With dividends included, the 12-month total return was -95.1%.

    What is VTGN's 5-year price change?

    VistaGen Therapeutics's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 70.0%. These figures leave out dividends.

    What is VTGN's 52-week high and low?

    VistaGen Therapeutics's 52-week high is $5.14 and its 52-week low is $0.16. Its latest price of $0.19 on Nov 17, 2026 is 96.3% below the high.

    What is VTGN's beta?

    VistaGen Therapeutics's 1-year beta against the S&P 500 is 1.88, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 96.7%.

    Is the VTGN chart free?

    Yes. Advanced Charting for VTGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.